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Abstract
Background Osteolytic lesions are common radiological
ﬁndings behind acetabular prosthetic cups. If the cup
is well-ﬁxed, the management is quite controversial.
Although implant exchange is the most reliable procedure,
in most cases it could be considered overtreatment, with
the potential for further morbidity and bone loss. Liner
exchange associated with lesion debridement and grafting
represents an alternative option that is less invasive. Here
we present our experiences from a small pilot study of
minimally invasive osteolysis treatment without bearings
exchange in patients with no evidence of liner wear.
Materials and methods Inclusion criteria: retroacetabular
osteolytic lesions in ceramic-on-polyethylene or metal-on-
polyethylene cementless total hip arthroplasties, affecting
more than 50% of the bone–prosthesis interface on anter-
oposterior radiography. Exclusion criteria: head penetration
into the liner, suspected loosening or infection. Six patients
were selected, two asymptomatic and four symptomatic.
Only the symptomatic patients accepted the proposed
treatment (performed between June 2004 and March 2006).
All of them received ﬂuoroscopy-assisted lesion debride-
ment through an iliac cortical window, morcellized bone
allograft mixed with autologous platelet-rich plasma, joint
exploration for culture and lavage through a small capsular
window. Patients were followed up clinically and radio-
logically at six months, 12 months, and then yearly.
Results Three patients out of four showed clinical and
radiological improvement. One showed radiological
improvement only, and recently underwent cup exchange
for subsequent loosening. The visual analog scale (VAS)
values for pain decreased on average, but not signiﬁcantly.
No major complications occurred. No recurrence was noted
at 2.25–4 years’ follow-up.
Conclusions Although the small series does not allow any
absolute conclusions to be drawn, the reported results seem
to justify further, wider studies. It is still unclear if osteo-
lytic lesions associated with no wear of the poly liner
would progress to implant failure if left untreated. Until the
problem is better understood, this procedure might repre-
sent an interesting way to prevent potential loosening and
severe bone loss in intact sockets.
Keywords Polyethylene  Wear  Osteolysis 
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Introduction
Osteolytic lesions are common radiological ﬁndings behind
acetabular cups in total hip arthroplasties (THA). The
frequency with which they are detected is strictly linked to
the sensitivity of the imaging technique used in follow-up.
Stulber et al. [1] demonstated that CT scan evaluation
of hip replacements raises the osteolysis rate to 48%.
The causes and developmental mechanisms of osteolytic
lesions are still the focus of research, but reaction to debris
seems to be the most reasonable explanation by far [2–6].
If this model is correct, periprosthetic osteolysis should be
considered a chronic inﬂammatory response to wear par-
ticles. Although polyethylene (PE) is the material that is
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and metal debris are not free from responsibility [7–9].
Particle size plays a major role in determining whether
debris phagocytosis will result in a lytic reaction [10, 11].
Larger particles ([1 lm) are more likely to be lined with
giant cells, so that the foreign body is virtually removed
from the biological environment, while submicron particles
can be phagocytosed by macrophages and induce their
activation. Activated cells release several proinﬂammatory
cytokines, such as IL-1 and TNF-a, whose effects on
osteoclastogenesis and osteoclast activity are well known.
This effect is probably mediated by resident osteoblasts
and stromal cells, which produce RANKL (receptor acti-
vator of the NF-kB ligand) in reponse to cytokine
stimulation. The interaction between RANKL and its
receptor RANK on the surface of hemopoietic precursors
and mature osteoclasts may induce both osteoclast pre-
cursor differentiation and mature osteoclast activation [12,
13]. Moreover, activated macrophages can take part
directly in bone resorption by producing metalloprotein-
ases, which digest the extracellular matrix. The RANK–
RANKL pathway is inhibited by a soluble competitor of
RANKL, osteoprotegerin (OPG), which is secreted by the
same cell population (osteoblasts and stromal cells) in
response to different stimuli (estradiol, TGF-b1, BMP-2,
etc.) [14]. The imbalance between local concentrations of
RANKL and OPG seems to be a key factor in bone
resorption and then in periprosthetic osteolysis [15].
Since wear is an unavoidable phenomenon of any arti-
ﬁcial articulation, but gross periprosthetic osteolyses affect
only a small number of all THAs, a ‘‘wear threshold’’ can be
deﬁned as the wear rate beyond which the biological
environment (i.e., periprosthetic bone) is not able to dispose
of debris withoutdetermining radiologically detectable lytic
lesions. 0.1–0.2 mm/y are commonly accepted linear wear
rate thresholds for polyethylene liners. Osteolysis is not
expected to occur below this threshold [16–18]. However,
PE wear is not necessarily a steady phenomenon, as bed-
ding-in wear [19] and rim wear by impingement [20] are
known to be supplementary mechanisms, and may cause
exceptions to the general rule. Thus, the occurrence (and
reoccurrence) of osteolysis is more difﬁcult to predict than
it would seem from the previous simple model. Lastly, it is
not easy to determine when osteolytic lesions will affect cup
stability and lead to aseptic loosening, as several factors are
involved: extent, location (dome/rim), and involvement of
the supportive cortical bone.
Naudie and Engh propose that osteolyses should be
treated surgically mainly if they are symptomatic or asso-
ciated with impending risk of wear-through (i.e., the PE
thickness is smaller than 1.5 mm). Otherwise, they suggest
treating asymptomatic lesions only if they develop early
after implantation (i.e., within ﬁve years) or they are
growing rapidly [21]. The authors substantially agree with
the surgical treatment indications provided by Chiang et al.
[22] who distinguish between three types of acetabular
osteolysis that are eligible for surgery:
– Type I: a well-ﬁxed cup that is modular, properly
oriented, intact (especially in relation to the locking
mechanism), with favorable track records, and that can
accommodate a sufﬁciently thick insert
– Type II: a well-ﬁxed cup that does not fulﬁl one of the
previous conditions
– Type III: a loose cup
Types II and III deserve standard revision, while type I
can be dealt with through liner exchange and local
debridement and grafting.
On the other hand, Chang et al. reviewed 62 conven-
tional revisions of well-ﬁxed acetabular components and
reported very good results, without severe complications
[23]. Thus, they advocate cup revision, especially in young
patients, for which surgery should be particularly reliable.
Undoubtedly debridement and grafting are not as effec-
tivewhenperformedthroughtheholesofthecuporacortical
window rather than after cup removal [24, 25], and recently
Engh et al. [26] demonstrated that the accuracy of the oste-
olysis grafting procedure is extremely low if the acetabular
component is left in situ, as signiﬁcant parts of the lesion
cannot be addressed. However, osteolysis resolution is not
clearly related to debridement and grafting, as isolated liner
exchangewasfoundtobeequallyeffectiveinseveralstudies
[27–29]. In other words, the removal of the source of debris
mightallowthespontaneoushealingoftheuntreatedlesions.
The purpose of the present pilot study was to test the
effectiveness (no recurrence nor subsequent loosening) and
the safety (absence of major complications) of the mini-
mally invasive prophylactic treatment of isolated osteolyses
without cup or liner exchange in apparently wearless THAs.
The rationale of this technique is based on the hypothesis
that the release of debris from radiologically intact liners
may depend mainly on bedding-in or rim-neck impinge-
ment. Since both phenomena may be self-limiting, local
treatment of the lesion and joint lavage might be an ade-
quate solution that is able to promote local healing without
incurring signiﬁcant morbidity (infection, dislocation).
Materials and methods
From June 2004 to March 2006 all of the outpatients with
THA followed up at our clinic were evaluated to detect any
retroacetabular osteolysis.
Standard plain X-rays were obtained in the anteroposte-
rior and axial views. Head penetration into the polyethylene
liner was measured manually by superimposing the
226 J Orthopaed Traumatol (2008) 9:225–231
123acetabular cup template onto the anteroposterior ﬁlm. The
technique was shown to be accurate enough for the purposes
of our research [30]. Osteolysis detection might have been
more sensitive if additional oblique views had been taken
[31–33], but the costs and radiation exposures involved
were considered excessive, since only gross lesions were
selected for treatment.
Retroacetabular osteolytic lesions in ceramic-on-poly-
ethylene or metal-on-polyethylene cementless total hip
arthroplasties, affecting more than 50% of the bone–pros-
thesis interface on anteroposterior radiography, were
considered eligible. The extent of interface involvement
was chosen instead of the lesion volume as it was easier to
measure and might be more predictive of future loosening.
However, no demonstration of such a predictive value was
found in the literature.
All of the cases showing head penetration into the liner
were excluded, as well as all of those whose clinical or
laboratory ﬁndings, X-rays or bone scans may have sug-
gested loosening or infection. Symptoms were not
considered relevant to selection, unless they clearly sug-
gested loosening or infection.
Six patients were found to satisfy all of the inclusion
criteria and none of the exclusion criteria. Four were mildly
symptomatic and accepted the proposed treatment, while
two were completely pain-free and declined. Descriptive
characteristics of the series are displayed in Table 1.
Pain was described as mild and activity-related by all
the patients. All of them complained of groin pain, while
only patient 1 also complained of buttock pain (Fig. 1).
The mean preoperative VAS (visual analog scale) was
36 mm, and the 95% conﬁdence interval was calculated to
lie between 20.91 and 51.09.
All of the lesions underwent ﬂuoroscopy-aided debride-
ment and grafting. The proximal part of a Smith–Petersen
approach was performed, the glutei were partly detached
from the anterior third of the iliac wing, and the external
iliac fossa was exposed [34]. The intermuscular interval
was developed distally until the superior part of the neo-
capsule was recognized. Then, to avoid affecting joint
stability, no further dissection was carried out.
A small capsular window was obtained and a sample of
periprosthetic ﬂuids was taken for culture. The peripros-
thetic space was then washed carefully by high-pressure
pulsatile lavage, with the aim of reducing the concentration
of debris particles. The iliac cortex was drilled under
ﬂuoroscopic guidance about 1.5–2 cm above the dome of
the cup. The hole was enlarged until a small curette could
be passed through. The lesion was then debrided as com-
pletely as possible, and several anteroposterior and oblique
views were obtained to check that all of the lesion had been
investigated and virtually emptied (Fig. 2).
Morcellized bone allograft was mixed with autologous
platelet-rich plasma (PRP) obtained using the GPS System
Table 1 Case series













1 Male 68 Left Metal–PE 13 39 15 Yes 4
2 Male 54 Right Ceramic–PE 6 30 16 Yes 3.2
3 Female 63 Right Ceramic–PE 3 27 29 Yes 3.2
4 Male 55 Right Ceramic–PE 5 48 31 Yes 2.25
Fig. 1a–c Patient 1. a Wide
retroacetabular osteolysis
13 years after total hip
arthroplasty. b one-year
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123(Biomet, Warsaw, IN, USA) from a venous blood sample
of the patient [35, 36] (Fig. 3). Approximately 10–15 cm
3
of the graft was tightly packed inside the cavity until it was
ﬁlled to the brim of the cortical hole. Lastly, the glutei
muscles and the tensor fasciae latae were reattached to the
iliac crest via transosseous suture and the wound was
closed.
All of the patients received one day of antibiotic pro-
phylaxis with intravenous cefazoline administration (2 g
before surgery and 1 g 6 h later). Low molecular weight
heparins were continued for 30 days after surgery. All of
the patients began tolerable weight-bearing from the ﬁrst
postoperative day, and crutches were used for two weeks
on average. The four patients were followed up on a reg-
ular basis at six months, 12 months, and then yearly. Plain
X-rays of the hip were taken and the pain VAS value was
recorded at each examination. The radiological images
were evaluated according to Linder’s stages of impacted
graft osseointegration [37]: no change and resorption were
interpreted as failures, while trabecular remodellng and
incorporation were interpreted as healing. Although the
series is extremely undersized, a paired Student’s t test was
performed to assess the expected reduction in VAS score,
and signiﬁcance was set at 0.05.
The study protocol was approved by each author. It
conforms to the Declaration of Helsinki and was accepted
by the Institutional Ethics Committee. All of the patients
provided written consent before their enrolment.
Results
None of the patients developed any major complications
(deep venous thrombosis, dislocation, infection). They
were discharged to home 3.9 days after surgery on average
(range: 3–5). At latest follow up, the mean pain VAS score
was 22.8, with the 95% conﬁdence interval reaching from
9.35 to 36.15. Thus, the improvement in symptoms was not
statistically signiﬁcant (p = 0.095).
All of the lesions were judged to be radiologically
healed, although one patient (patient 3) had developed a
growing radiolucent line around the cup at last X-ray
(three years after the procedure). The component was
considered to be loose and then revised. The surgical
ﬁndings conﬁrmed the healing of the lesion, and so a press-
ﬁt hemispherical cup could be implanted with no need for
further bone grafting.
Discussion
Total hip arthroplasty, as well as any other artiﬁcial joint,
goes through two working phases: the bedding-in and
steady state phases. Bedding-in is characterized by fast
radiographical penetration of the head, which is partly due
to the head settling into the liner and to the liner settling
into the metal back, and partly due to creep. Creep is the
plastic deformation that any solid material undergoes when
load is applied for a sufﬁciently long period [38]. In the
polyethylene liner, it is intended that creep should increase
the contact area, thus lowering the contact pressure. In
other words, it improves the frictional performance of the
bearing [39]. In the bedding-in phase, head penetration
overestimates interface wear by far, as settling-in and
deformation are likely to play a major role [40]. However,
Fig. 2 Curettage under ﬂuoroscopic control
Fig. 3 PRP injection during bone grafting
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123the presence of a smaller contact area during this early
phase is likely to result in signiﬁcantly higher wear than
during the following steady phase, in which better con-
gruency is obtained. True bedding-in wear is a difﬁcult-to-
measure phenomenon in THAs with PE liners, because of
the important confounding variables listed above, but it is a
well-known, easier-to-measure tribological phenomenon in
metal-on-metal bearings [41].
The steady state phase occurs six months to two years
after implantation, and is characterized by a constant, low
speed of head penetration. New crosslinked UHMWPE has
a longer bedding-in phase (1–2 years) compared to con-
ventional UHMWPE (six months) [42], and this different
viscoelastic behavior may result in greater bedding-in
wear. However, the true steady-state linear wear of modern
high-quality polyethylene is slightly above the 0.1 mm/
year threshold, while the steady-state wear of crosslinked
PE is so low that it is barely measurable, even with ra-
diostereometric assays [43].
Including the bedding-in penetration, Dorr reported
0.029 mm/year for Durasul (Sulzer, Austin, TX, US) [44],
Engh reported 0.01 for Marathon (DePuy, Warsaw, IN,
US) [45], D’Antonio reported 0.055 for Crossﬁre (Stryker,
Mahwah, NJ, US) [46], and Digas reported 0.016 for
Longevity (Zimmer, Warsaw, IN, US) [42].
If higher interface wear during the early phase of joint
functioning is quite reasonable, higher rim wear looks even
more logical. Rim wear is caused by impingement between
the prosthetic neck and the rim of the liner. It is likely to
occur when prosthetic components are poorly oriented or
low-clearance design features (e.g., protruding liners, small
head-to-neck ratio) are chosen. Baldini et al. [20] found
that 56% of explanted acetabular cups in THA revision
show rim damage. Impingement is now being found to be a
relevant factor in THA failure. It initiates at least three
different pathomechanisms: it causes loss of material from
the edge of the liner (direct effect); it provokes head sub-
luxation and thus increases articular wear; and it has been
demonstrated to induce backside wear [47, 48], which
has otherwise been almost eliminated in modern acetabu-
lar cups [49]. Obviously the direct effect leads to a
reduction in the overhanging edge of the liner, which is
shaped by impingement through selective wear of the
impinging segments. In other words, impingement may
be a self-limiting phenomenon, except in the case of
severe malpositioning or the wrong choice of prosthetic
components.
From what is written above, it follows that PE wear of
the articular surface, the rim and the backside is assumed to
be higher during the early phase of implant life than the
later phase, although no study has actually addressed this
problem to the best of our knowledge. This hypothesis was
the principle of our bearings-retaining approach: if the
wear decreases over time, the recurrence of osteolysis after
treatment would be improbable, notwithstanding the
retention of the articular components. The choice of
including PRP in our management strategy was based on
the biology of osteolysis, which seems to be regulated
mainly by the positive effect of the RANK–RANKL
pathway and by the negative effect of OPG, as described
above.
PRP is an effective source of TGF-b2, PDGF-AB and
IGF-1, growth factors released by activated platelets and
capable of a regenerative response that might be useful in
local bone healing [50–52]. Speciﬁcally, TGF-b2 is known
to decrease RANKL levels and to increase OPG levels,
thus interrupting the main osteolysis pathomechanism
[15]. Whether PRP increases the local concentration of
bone morphogenetic protein-2 (BMP-2) too is a matter
of contention [53, 54]; if this is the case, BMP-2 would
be another important stimulus that augments OPG levels
[15].
All of these considerations make PRP a potentially
useful aid, promoting lesion healing and preventing it from
relapse.
One cannot draw deﬁnitive conclusions from the results
presented here, as the series is too small and the follow-up
too short. However, the radiological healing observed in
all cases and the absence of recurrence are consistent
with the fundamental hypothesis: that most osteolyses that
occur without detectable polyethylene wear may be the
result of an initial high-wear phase of implant life (perhaps
associated with individual hyper-reactivity of the host),
after which debris release is insufﬁcient to determine
relapse.
Although pain relief is statistically nonsigniﬁcant, the
inadequate sample size makes statistical signiﬁcance less
reliable. Moreover, such mild discomfort may not be
related to osteolysis, the resolution of which seems to be
much more important than the disappearance of symptoms.
The strength of the relation between osteolysis and
loosening is still unknown: even if patient 3 seems to
demonstrate that loosening may develop even with oste-
olysis healing, one could postulate that occult loosening
may have already been occurring at the time of treatment.
The surgical importance of healing the lesion was shown in
the same case: the restored bone stock allowed a primary
cup to be implanted without any further acetabular
reconstruction.
Our preliminary results cannot be used to justify the
routine management of retroacetabular osteolyses without
bearings exchange, but hopefully it may provide the basis
for further investigations on larger cohorts.
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